For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| GSK561679 | GSK561679, oral administration, 350mg/day, 6 week administration GSK561679: GSK561679, oral administration, 350mg/day, 6 week administration | None | None | 1 | 63 | 55 | 63 | View |
| Placebo | Placebo compound treatment for comparison with IP Placebo: Placebo compound treatment for comparison with IP | None | None | 1 | 65 | 55 | 65 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Contusion | None | Injury, poisoning and procedural complications | None | View |
| Neck Pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Myalgia | None | Musculoskeletal and connective tissue disorders | None | View |
| Dizziness | None | Musculoskeletal and connective tissue disorders | None | View |
| Tinnitus | None | Ear and labyrinth disorders | None | View |
| Hot Flush | None | Endocrine disorders | None | View |
| Non-cardiac chest pain | None | Endocrine disorders | None | View |
| Vision Blurred | None | Eye disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Diarrhea | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Dyspepsia | None | Gastrointestinal disorders | None | View |
| Constipation | None | Gastrointestinal disorders | None | View |
| Dry Mouth | None | Gastrointestinal disorders | None | View |
| Abdominal Pain | None | Gastrointestinal disorders | None | View |
| Abdominal distension | None | Gastrointestinal disorders | None | View |
| Flatulence | None | Gastrointestinal disorders | None | View |
| Irritability | None | General disorders | None | View |
| Disturbance in attention | None | General disorders | None | View |
| Hypersensitivity | None | General disorders | None | View |
| Upper Respiratory Tract Infection | None | Infections and infestations | None | View |
| Arthralgia | None | Musculoskeletal and connective tissue disorders | None | View |
| Muscle spasm | None | Musculoskeletal and connective tissue disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Sedation | None | Nervous system disorders | None | View |
| Migraine | None | Nervous system disorders | None | View |
| Insomnia | None | Psychiatric disorders | None | View |
| Depression | None | Psychiatric disorders | None | View |
| Cough | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhinitis Allergic | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Sinusitis | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Oropharyngeal Pain | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Pruritis | None | Skin and subcutaneous tissue disorders | None | View |